Application of Tumor Markers CEA, TPA, and SCC-Ag in Patients with Low-Risk FIGO Stage IB and IIA Squamous Cell Carcinoma of the Uterine Cervix

By Juang C.-M.   Wang P.-H.   Yen M.-S.   Lai C.-R.   Ng H.-T.   Yuan C.-C.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Stage IB1 vs IB2 Carcinoma of the Cervix: Should the New FIGO Staging System Define Therapy?

By Grigsby P.W.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 135-136

Academic Press

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Stage IB2 Squamous Cell Carcinoma of the Cervix

By Serur E.   Mathews R.P.   Gates J.   Levine P.   Maiman M.   Remy J.C.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 348-356

Elsevier

Access to resources Recommend Favorite

Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival

By Zhu Weipei  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1653-1659

Springer Publishing Company

Access to resources Recommend Favorite

LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix

By Hedman Håkan   Lindström Annika K.   Tot Tibor   Stendahl Ulf   Henriksson Roger   Hellberg Dan  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 812-815

Informa Healthcare

Access to resources Recommend Favorite